Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Patient admissions at the only 20-bed Chest Disease Hospital in the Rangpur division have remained suspended since June after ...

The World Health Organization praised India for making notable progress in tuberculosis detection and treatment, although the ...

Seattle & King County is actively addressing a confirmed case of active tuberculosis (TB) linked to the Aegis Living ...

Tuberculosis (TB) remains one of the world's deadliest infectious killers, claiming over 1.2 million lives and affecting an ...

Global tuberculosis rates fell about 2% in 2024 from the previous year, according to a World Health Organization report, ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...